{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:02:36Z","timestamp":1782738156389,"version":"3.54.5"},"reference-count":44,"publisher":"The Journal of Rheumatology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>E-cadherin is a potent adherens junction molecule implicated in tissue morphogenesis, epithelial functioning, and immune regulation. Serum levels of soluble E-cadherin (sE-cadherin), an end product of proteolytic cleavage of E-cadherin, is increased in patients with cancer, infections, and inflammation-related diseases. The aim of our study was to measure serum levels of sE-cadherin in systemic lupus erythematosus (SLE) and to determine associations between serum levels of sE-cadherin and markers of inflammation and organ damage in female patients with SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Serum levels of sE-cadherin were analyzed by ELISA in 150 female patients with SLE and 31 healthy women. Simple and multiple regression analyses between sE-cadherin levels and disease-related variables were performed in patients with SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Serum levels of sE-cadherin were elevated in patients with SLE compared with levels in healthy controls. sE-cadherin levels correlated positively with age, disease duration, SLE Collaborating Clinics Damage Index, erythrocyte sedimentation rate (ESR), s-creatinine, cholesterol, triglycerides, interleukin 6, and matrix metalloproteinase-3. In multiple regression analysis, s-creatinine, age, ESR, and triglycerides remained determinants of sE-cadherin. Within the patients with SLE, higher sE-cadherin levels were found only in patients with renal damage, i.e., s-creatinine &gt; 90<jats:italic>\u03bc<\/jats:italic>mol\/l, glomerular filtration rate &lt; 50 ml\/min, or renal involvement ever by SLE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Our study demonstrates significantly elevated serum levels of sE-cadherin in women with SLE compared with healthy women. The levels of sE-cadherin were positively correlated to s-creatinine, age, ESR, and triglycerides. Significantly elevated sE-cadherin levels were observed only in patients with renal damage.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.130518","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T00:09:50Z","timestamp":1378080590000},"page":"1677-1682","source":"Crossref","is-referenced-by-count":9,"title":["Soluble E-cadherin in Systemic Lupus Erythematosus"],"prefix":"10.3899","volume":"40","author":[{"given":"Tao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Almehed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Carlsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Forsblad-d\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2013,9,1]]},"reference":[{"key":"2018112909320188000_40.10.1677.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8281-1"},{"key":"2018112909320188000_40.10.1677.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384289"},{"key":"2018112909320188000_40.10.1677.3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/eji.201243168","article-title":"E-cadherin: from epithelial glue to immunological regulator","volume":"43","author":"Van den Bossche","year":"2012","journal-title":"Eur J Immunol"},{"key":"2018112909320188000_40.10.1677.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091527"},{"key":"2018112909320188000_40.10.1677.5","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.160.8.4067","article-title":"Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo","volume":"160","author":"Jakob","year":"1998","journal-title":"J Immunol"},{"key":"2018112909320188000_40.10.1677.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.08.015"},{"key":"2018112909320188000_40.10.1677.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1188510"},{"key":"2018112909320188000_40.10.1677.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.017"},{"key":"2018112909320188000_40.10.1677.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221598"},{"key":"2018112909320188000_40.10.1677.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9104-8"},{"key":"2018112909320188000_40.10.1677.11","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.634"},{"key":"2018112909320188000_40.10.1677.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.078"},{"key":"2018112909320188000_40.10.1677.13","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000094189.93805.17"},{"key":"2018112909320188000_40.10.1677.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602599"},{"key":"2018112909320188000_40.10.1677.15","first-page":"769","article-title":"Preoperative serum E-cadherin assay in patients with ovarian carcinoma","volume":"19","author":"Gadducci","year":"1999","journal-title":"Anticancer Res"},{"key":"2018112909320188000_40.10.1677.16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/bjc.1998.309","article-title":"Serum concentrations of soluble adhesion molecules in patients with colorectal cancer","volume":"77","author":"Velikova","year":"1998","journal-title":"Br J Cancer"},{"key":"2018112909320188000_40.10.1677.17","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(95)00493-9"},{"key":"2018112909320188000_40.10.1677.18","first-page":"83","article-title":"The clinical significance of soluble E-cadherin in nonsmall cell lung cancer","volume":"28","author":"Charalabopoulos","year":"2006","journal-title":"Exp Oncol"},{"key":"2018112909320188000_40.10.1677.19","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/76.5.629"},{"key":"2018112909320188000_40.10.1677.20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2133.1995.tb00720.x","article-title":"Soluble E-cadherin: a novel cutaneous disease marker","volume":"132","author":"Matsuyoshi","year":"1995","journal-title":"Br J Dermatol"},{"key":"2018112909320188000_40.10.1677.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.10.010"},{"key":"2018112909320188000_40.10.1677.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2005.01698.x"},{"key":"2018112909320188000_40.10.1677.23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem105"},{"key":"2018112909320188000_40.10.1677.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"2018112909320188000_40.10.1677.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"2018112909320188000_40.10.1677.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400506"},{"key":"2018112909320188000_40.10.1677.27","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"2018112909320188000_40.10.1677.28","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311425528"},{"key":"2018112909320188000_40.10.1677.29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1242\/jcs.114.1.111","article-title":"Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1","volume":"114","author":"Noe","year":"2001","journal-title":"J Cell Sci"},{"key":"2018112909320188000_40.10.1677.30","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199808)41:8<1456::AID-ART16>3.0.CO;2-0"},{"key":"2018112909320188000_40.10.1677.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.156.1.1","article-title":"Matrix metalloproteinases in immunity","volume":"156","author":"Goetzl","year":"1996","journal-title":"J Immunol"},{"key":"2018112909320188000_40.10.1677.32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.150.2.644","article-title":"Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock","volume":"150","author":"Newman","year":"1993","journal-title":"J Immunol"},{"key":"2018112909320188000_40.10.1677.33","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.4776"},{"key":"2018112909320188000_40.10.1677.34","doi-asserted-by":"publisher","DOI":"10.1159\/000096947"},{"key":"2018112909320188000_40.10.1677.35","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.31390"},{"key":"2018112909320188000_40.10.1677.36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.14"},{"key":"2018112909320188000_40.10.1677.37","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-010-8207-1"},{"key":"2018112909320188000_40.10.1677.38","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000106015.29070.E7"},{"key":"2018112909320188000_40.10.1677.39","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080983"},{"key":"2018112909320188000_40.10.1677.40","first-page":"409","article-title":"Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis","volume":"16","author":"Kotajima","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909320188000_40.10.1677.41","doi-asserted-by":"publisher","DOI":"10.1002\/art.11264"},{"key":"2018112909320188000_40.10.1677.42","first-page":"713","article-title":"Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964\u201395","volume":"31","author":"Bjornadal","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909320188000_40.10.1677.43","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955"},{"key":"2018112909320188000_40.10.1677.44","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802037370"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.130518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T07:34:24Z","timestamp":1688456064000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.130518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,1]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.3899\/jrheum.130518"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.130518","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,1]]}}}